Valuation: PharmaEssentia Corporation

Market Cap 495B 15.52B 13.52B 12.8B 11.63B 21.72B 1,487B 21.83B 152B 58.93B 755B 58.31B 57.01B 2,418B P/E 2026 *
45.1x
P/E 2027 * 28.4x
Enterprise Value 469B 14.69B 12.8B 12.11B 11B 20.56B 1,407B 20.66B 144B 55.77B 715B 55.19B 53.96B 2,289B EV / Sales 2026 *
16.5x
EV / Sales 2027 * 11.5x
Free-Float
77.98%
Yield 2026 *
0.33%
Yield 2027 * 0.2%
1 day-0.83%
1 week-11.15%
Current month-14.34%
1 month-20.33%
3 months+33.76%
6 months+104.25%
Current year+182.04%
1 week 1,165
Extreme 1165
1,315
1 month 1,165
Extreme 1165
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-11.15%+169.70%+295.44% 15.72B
+1.76%+3.62%+49.92%+101.12% 69.69B
+2.29%+1.43%+38.39%+77.80% 61.24B
+0.43%-3.16%-14.86%+364.26% 26.77B
+0.32%+2.58%+29.26%+14.12% 26.12B
+3.32%+2.74%+0.91%-9.17% 24.07B
+1.49%+7.73%+26.85%-13.79% 20.39B
+2.10%+1.17%+43.67%+172.13% 14.07B
+0.17%-4.07%-9.71%+484.05% 14.03B
+4.22%+4.65%-1.66%+882.87% 13.8B
Average +1.55%-1.20%+33.25%+236.88% 28.59B
Weighted average by Cap. +1.66%+0.12%+34.59%+166.04%

Financials

2026 *2027 *
Net sales 28.33B 888M 773M 732M 665M 1.24B 85.03B 1.25B 8.72B 3.37B 43.21B 3.34B 3.26B 138B 40.06B 1.26B 1.09B 1.04B 940M 1.76B 120B 1.77B 12.33B 4.77B 61.11B 4.72B 4.61B 196B
Net income 11.02B 345M 301M 285M 259M 483M 33.08B 486M 3.39B 1.31B 16.81B 1.3B 1.27B 53.82B 17.69B 554M 483M 457M 415M 776M 53.1B 780M 5.44B 2.11B 26.99B 2.08B 2.04B 86.39B
Net Debt -26.52B -831M -724M -685M -623M -1.16B -79.62B -1.17B -8.16B -3.16B -40.46B -3.12B -3.05B -130B -34.73B -1.09B -948M -897M -815M -1.52B -104B -1.53B -10.69B -4.13B -52.98B -4.09B -4B -170B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-09-16 NT$1,195.00 -0.83% 2,197,868
26-09-16 NT$1,205.00 0.00% 2,565,604
26-09-15 NT$1,205.00 +1.26% 2,315,449
26-09-14 NT$1,190.00 -7.03% 5,500,524
26-09-11 NT$1,280.00 -3.03% 2,676,454
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,195.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+16.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!